Selma Bouden, Hiba Ben Ayed, Haifa Khemir, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula
{"title":"类风湿关节炎生物制剂治疗教育的疗效观察","authors":"Selma Bouden, Hiba Ben Ayed, Haifa Khemir, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula","doi":"10.1002/msc.70060","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to assess the effects of a patient therapeutic education (PTE) programme on the course of the disease and treatment management skills in rheumatoid arthritis (RA) patients treated with biologics.</p><p><strong>Methods: </strong>From January to December 2023, 52 RA patients participated in a face-to-face education session of 1 h, delivered to groups of four to six patients by 2 rheumatologists qualified in PTE. Disease activity, quality of life parameters and patient's skills using the BioSecure score were assessed before the education programme and 3 months later.</p><p><strong>Results: </strong>A statistically significant decrease in mean pain visual Analogue Scale (p = 0.001), mean morning stiffness duration (p = 0.002), mean number of night awakenings (p = 0.01), mean tender joints count (p = 0.001) and mean 28-Disease-activity-score (p = 0.001) were observed 3 months after the PTE. A statistically significant decrease in functional status (HAQ) and fatigue scores (FACIT-F) was observed after PTE (p = 0.03 and p = 0.001, respectively). The mean BioSecure score climbed from 47.9 ± 14.9 at baseline to 74.8 ± 12.9 after PTE (p = 0.001). The variation of BioSecure score was significantly more important in patients with third-level education, patients receiving subcutaneous biotherapy and those on TNF alpha inhibitors therapy.</p><p><strong>Conclusion: </strong>PTE may be effective in improving clinical outcomes and safety skills in RA patients receiving biological treatment.</p>","PeriodicalId":46945,"journal":{"name":"Musculoskeletal Care","volume":"23 1","pages":"e70060"},"PeriodicalIF":1.5000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics.\",\"authors\":\"Selma Bouden, Hiba Ben Ayed, Haifa Khemir, Leila Rouached, Aicha Ben Tekaya, Ines Mahmoud, Raoudha Tekaya, Olfa Saidane, Leila Abdelmoula\",\"doi\":\"10.1002/msc.70060\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>We aimed to assess the effects of a patient therapeutic education (PTE) programme on the course of the disease and treatment management skills in rheumatoid arthritis (RA) patients treated with biologics.</p><p><strong>Methods: </strong>From January to December 2023, 52 RA patients participated in a face-to-face education session of 1 h, delivered to groups of four to six patients by 2 rheumatologists qualified in PTE. Disease activity, quality of life parameters and patient's skills using the BioSecure score were assessed before the education programme and 3 months later.</p><p><strong>Results: </strong>A statistically significant decrease in mean pain visual Analogue Scale (p = 0.001), mean morning stiffness duration (p = 0.002), mean number of night awakenings (p = 0.01), mean tender joints count (p = 0.001) and mean 28-Disease-activity-score (p = 0.001) were observed 3 months after the PTE. A statistically significant decrease in functional status (HAQ) and fatigue scores (FACIT-F) was observed after PTE (p = 0.03 and p = 0.001, respectively). The mean BioSecure score climbed from 47.9 ± 14.9 at baseline to 74.8 ± 12.9 after PTE (p = 0.001). The variation of BioSecure score was significantly more important in patients with third-level education, patients receiving subcutaneous biotherapy and those on TNF alpha inhibitors therapy.</p><p><strong>Conclusion: </strong>PTE may be effective in improving clinical outcomes and safety skills in RA patients receiving biological treatment.</p>\",\"PeriodicalId\":46945,\"journal\":{\"name\":\"Musculoskeletal Care\",\"volume\":\"23 1\",\"pages\":\"e70060\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Musculoskeletal Care\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/msc.70060\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Musculoskeletal Care","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/msc.70060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
Efficacy of Therapeutic Education for Patients With Rheumatoid Arthritis Treated With Biologics.
Introduction: We aimed to assess the effects of a patient therapeutic education (PTE) programme on the course of the disease and treatment management skills in rheumatoid arthritis (RA) patients treated with biologics.
Methods: From January to December 2023, 52 RA patients participated in a face-to-face education session of 1 h, delivered to groups of four to six patients by 2 rheumatologists qualified in PTE. Disease activity, quality of life parameters and patient's skills using the BioSecure score were assessed before the education programme and 3 months later.
Results: A statistically significant decrease in mean pain visual Analogue Scale (p = 0.001), mean morning stiffness duration (p = 0.002), mean number of night awakenings (p = 0.01), mean tender joints count (p = 0.001) and mean 28-Disease-activity-score (p = 0.001) were observed 3 months after the PTE. A statistically significant decrease in functional status (HAQ) and fatigue scores (FACIT-F) was observed after PTE (p = 0.03 and p = 0.001, respectively). The mean BioSecure score climbed from 47.9 ± 14.9 at baseline to 74.8 ± 12.9 after PTE (p = 0.001). The variation of BioSecure score was significantly more important in patients with third-level education, patients receiving subcutaneous biotherapy and those on TNF alpha inhibitors therapy.
Conclusion: PTE may be effective in improving clinical outcomes and safety skills in RA patients receiving biological treatment.
期刊介绍：
Musculoskeletal Care is a peer-reviewed journal for all health professionals committed to the clinical delivery of high quality care for people with musculoskeletal conditions and providing knowledge to support decision making by professionals, patients and policy makers. This journal publishes papers on original research, applied research, review articles and clinical guidelines. Regular topics include patient education, psychological and social impact, patient experiences of health care, clinical up dates and the effectiveness of therapy.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
